遗传毒性
微核试验
碎屑成因
毒性
未观察到不良反应水平
药理学
毒理
微核
医学
最大耐受剂量
急性毒性
生物
药代动力学
内科学
作者
Kara D. Lewis,Michael Falk
标识
DOI:10.1016/j.fct.2022.113301
摘要
A battery of studies was conducted to examine the toxicological potential of dihydroberberine (DHBBR), a derivative of berberine (BBR). The genotoxicity studies conducted on DHBBR, including the bacterial reverse mutation test, the mouse lymphoma assay, and the in vivo micronucleus test, showed that DHBBR is non-mutagenic and non-clastogenic. An acute oral toxicity study revealed that the LD50 of DHBBR in female Sprague Dawley rats was greater than 2000 mg/kg bw. In a 14-day oral dose range finding study, the maximum tolerated dose was the high dose, 120 mg/kg bw/day. Based on a 90-day oral toxicity study in male and female Sprague Dawley rats, it was concluded that the NOAEL for DHBBR is 100 mg/kg bw/day, the highest dose tested.
科研通智能强力驱动
Strongly Powered by AbleSci AI